---
title: "TriSalus Life Sciences names Richard Henry Marshall as chief medical officer in initial beneficial ownership filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291187427.md"
description: "TriSalus Life Sciences filed an initial beneficial ownership report for Chief Medical Officer Richard Henry Marshall. The filing discloses that Marshall holds 30,000 common shares and employee stock options for 133,000 additional shares, with exercise prices ranging from $4.01 to $5.55. This information was published via EDGAR on June 29, 2026."
datetime: "2026-06-29T20:31:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291187427.md)
  - [en](https://longbridge.com/en/news/291187427.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291187427.md)
---

# TriSalus Life Sciences names Richard Henry Marshall as chief medical officer in initial beneficial ownership filing

-   TriSalus Life Sciences CMO Richard Henry Marshall reported 30,000 common shares held, plus employee stock options for 133,000 shares priced at $4.01-$5.55. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-046011), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TLSI.US](https://longbridge.com/en/quote/TLSI.US.md)
- [TLSIW.US](https://longbridge.com/en/quote/TLSIW.US.md)

## Related News & Research

- [Analyst Justin Walsh Reaffirms Buy on TriSalus After Strong Q2 Results, CMS Reimbursement Tailwinds, and Growth Outlook Through 2026](https://longbridge.com/en/news/295431262.md)
- [Intapp CEO John T. Hall disposes of 3,000 common shares for $111,120](https://longbridge.com/en/news/295703205.md)
- [Intapp CEO John T. Hall disposes of 146,674 common shares worth 5.41 million](https://longbridge.com/en/news/295273055.md)
- [Eton Pharma COO Danka Radosavljevic files initial beneficial ownership statement](https://longbridge.com/en/news/295709440.md)
- [Business First Bancshares director William G. Hall disposes of 11,389 common shares worth $364,098.33](https://longbridge.com/en/news/295272946.md)